SHANLAX International Journal of Economics shanlax #SINCE1990 http://www.shanlaxjournals.com 52 Economic Perspectives on the Impact of CovId vaccines A. Sangamithra Professor, Department of Economics, Bharathiar University, Coimbatore, Tamil Nadu, India https://orcid.org/0000-0003-4761-8150 S. Thilagavathy Ph.D. Research Scholar, Department of Economics Bharathiar University, Coimbatore, Tamil Nadu, India Abstract Vaccination and the impact on health on the world’s people is very diffcult to exaggerate. The main aim is to treat people with mental health issues and substance use of disorder. Vaccination is cru- cial in terms of ensuring the overall health conditions and well–being. The development of vaccines is an expensive and lengthy process. Depreciation is high and takes multiple candidates and long years to produce a licensed vaccine. The access to vaccines that prevent life-threatening infectious diseases remains not equal to all the population. The benefts of vaccination derive from health and economic benefts and the health benefts have diminishing returns as a result of high-risk individuals been vaccinated frst. Economic benefts depend both on the health benefts and on how reduced risk of infection and death translates into a leading general economic activity. Department of Government is required to perform a systematic economic analyses of vaccines and to justify their given pressure on both private and public fnances on a global level; provoke in the year 2008 fnancial crash. Mostly, the government supports charities and non-governmental organizations, where people invest in these, with the hope of improving the health conditions. Keywords: vaccine, diseases, Activity, Infection, Justify, Programs, Expectancy, Morbidity Introduction The development of vaccines is an expensive and lengthy process. Depreciation is high and takes multiple candidates and long years to produce a licensed vaccine. The access to vaccines that prevent life-threatening infectious diseases remains not equal to all the population. It estimates that vaccines have prevented six million deaths annually from vaccine – preventable disease. For the past few decades, the vaccine industry and scientifc community have asked to respond immediately to epidemics of H1N1 infuenza, Zika, Ebala and now it is SARS COV-2. By 2055, it is estimated that the earth’s population to reach almost ten billion given by (Department of Economic and Vaccines that can prevent most of the disease and prolong life expectancy across many countries. (Charlene M.C Rodrigues et al. 2020). Pandemic will cause high demand for vaccines all around the world. Both serologic studies and clinical studies will need to confrm which populations remain at the highest level of risk once the vaccines are available and could form the basis for establishing a fair vaccine for allocation system. Group of seven countries has already called it a global organization in which the planning must get starts while the vaccine development activity proceeds. COVID-19 – a pandemic situation has caused the hundreds or thousands of people upended the lives in billions and causes a trillion dollars in economic loss. Life is unlikely to return to normal life. What’s unique about India is that it has the expertise for low-cost per-unit vaccine production of vaccines. oPEN ACCESS Manuscript ID: ECO-2021-09023730 Volume: 9 Issue: 2 Month: March Year: 2021 P-ISSN: 2319-961X E-ISSN: 2582-0192 Received: 10.01.2021 Accepted: 15.02.2021 Published: 01.03.2021 Citation: Sangamithra, A., and S. Thilagavathy. “Economic Perspectives on the Impact of COVID Vaccines.” Shanlax International Journal of Economcis, vol. 9, no. 2, 2021, pp. 52-54. DOI: https://doi.org/10.34293/ economics.v9i2.3730 This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License